Summary & Overview
HCPCS J0611: Injection, Calcium Gluconate, per 10 ml
HCPCS Level II code J0611 denotes a 10 ml injectable dose of calcium gluconate, a medication frequently used in acute care to correct hypocalcemia and manage certain critical electrolyte emergencies. Nationally, coding for calcium gluconate administration affects hospital billing for emergency and inpatient encounters where prompt calcium replacement is required.
This analysis covers coverage and reimbursement benchmarks for major national payers: Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of typical sites of service, common billing considerations tied to medication administration, and payer-specific coverage patterns where available.
The publication provides clinical context about why calcium gluconate injections are billed separately, explains the service line implications for acute care delivery, and highlights areas where policy updates or documentation practices influence payment. Data not available in the input is noted explicitly. The content is intended for clinicians, billing professionals, and policy analysts seeking a national perspective on coding and billing for injectable calcium gluconate.
Billing Code Overview
HCPCS Level II code J0611 describes an injection of calcium gluconate, specified as per 10 ml. The service represents administration of an intravenous or intraosseous calcium replacement product typically used in critical care or emergency settings to treat hypocalcemia or related electrolyte disturbances.
Service Type: Drug administration (injectable medication)
Typical Site of Service: Hospital inpatient, emergency department, or other acute care settings
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult presenting to the emergency department or intensive care unit with acute symptomatic hypocalcemia, calcium channel blocker overdose, or severe hyperkalemia requiring intravenous calcium stabilization. The clinical workflow begins with triage and assessment (vital signs, cardiac monitoring, and point-of-care or laboratory serum electrolytes). When indicated by symptoms (perioral numbness, tetany, prolonged QT, arrhythmia) or ECG changes, the treating clinician orders intravenous calcium replacement. Pharmacy prepares calcium gluconate in a 10 mL vial (per J0611) and a nurse administers the medication intravenously (typically slow IV push or diluted infusion) under continuous cardiac monitoring. Documentation includes indication, dose and route, lot number, time, response, and any adverse reaction. Post-administration monitoring includes serial ECGs, repeat electrolytes, and observation for extravasation or allergic reaction. Disposition may be observation, admission, or transfer to higher level care depending on clinical response.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | When unusually high work or complexity related to administration or preparation is documented and supported. |